Nanomedic Inc.

Salt Lake City, UT

UEI
V7BHHGN2M427
CAGE
5AYW3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
417 Wakara Way #3325, Salt Lake City, UT 84108, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Developing novel therapeutic approaches for osteopenia and osteoporosis in patients with sickle cell disease R43AR077344 National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH) $248,486
A therapeutic approach for potential prevention of aromatase inhibitor-induced bone loss R43AG060819 National Institute on Aging (NIH) $222,976
A method for early and easy detection of alzheimer's disease R43AG052271 National Institute on Aging (NIH) $540,125
New therapeutics targeting skeletal excessive FE for thalassemia major bone loss R43HD088253 National Institute of Child Health and Human Development (NIH) $229,998
Novel therapeutics for postmenopausal osteoporosis R43TR000572 National Institutes of Health $187,717

Quick answers

Is Nanomedic Inc. registered in SAM.gov?

Yes. Nanomedic Inc.'s SAM.gov registration is active through September 26, 2027.

What is Nanomedic Inc.'s most recent federal award?

Nanomedic Inc.'s most recent federal grant award is Developing novel therapeutic approaches for osteopenia and osteoporosis in patients with sickle cell disease (R43AR077344), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH), on September 10, 2020.

On GovTribe

See Nanomedic Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login